Recent news on

First2Print Transforms Rooms for Television’s ``Extreme Makeover ...  -  May 4, 2007
Business Wire (press release),For this project, First2Print digitally printed pre-treated fabrics from DigiFab Systems for several of the makeover rooms. For the pop-tab theme room with

Rodman & Renshaw Global Healthcare Conference 2007 Presenter Profiles  -  May 11, 2007
American Digital Networks (press release),...biologics for critical care which are FDA approved and currently sold in the US: CroFab(TM), a pit viper antivenom and DigiFab(TM), a digoxin antidote.

Protherics PLC - Research Update  -  27 Mar 2007
Genetic Engineering News (press release),CroFab(TM) (pit viper antivenom) and DigiFab(TM) (digoxin antidote) which were developed by Protherics and are sold, in the US, through Fougera Inc,

Protherics to Receive £10 Million Milestone from AstraZeneca  -  Mar 12, 2007
PharmaLive.com (press release),In addition the Company has in-licensed intellectual property relating to the use of anti-digoxin polyclonal antibody fragments such as DigiFab™ and GSK’s

Protherics puts DigiFab up for Canadian approval  -  Jan 9, 2007
Pharma Times (subscription),Protherics of the UK says that it has put forward a New Drug Submission to the Health Products and Food Branch of Health Canada for DigiFab,

Protherics submits DigiFab for approval in Canada  -  Jan 8, 2007
Hemscott,LONDON (AFX) - Protherics PLC said has submitted an application for marketing approval for its digoxin antidote DigiFab in Canada.

TechMARK movers: Psion soars, Protherics trips  -  Jan 8, 2007
ShareCast,The biopharmaceutical group said DigiFab is the leading digoxin antidote in the US where it is approved for the treatment of life-threatening or potentially

Protherics PLC announces Voraxaze(TM) Update  -  Jan 12, 2007
PipelineReview.com (press release),...relating to the use of anti-digoxin polyclonal antibody fragments such as DigiFab™ and GSK's Digibind® in the treatment of pre-eclampsia and eclampsia.

Protherics PLC announces Regulatory Application  -  Jan 7, 2007
Genetic Engineering News (press release),..."DigiFab is now the established market leader in the digoxin antidote market, worth an estimated $30 million per annum, and we are consolidating this

Protherics' DigiFab to Replace Digitalis Antidot in Europe  -  Nov 27, 2006
PharmaLive.com (press release),...sales revenues (?.7m in the year ended 31 March 2006) are derived from two critical care products, CroFab(tm) (pit viper antivenom) and DigiFab(tm) (digoxin ...

Protherics' DigiFab(TM) to replace Digitalis Antidot(R) in Europe  -  Nov 28, 2006
PipelineReview.com (press release),...revenues (£17.7m in the year ended 31 March 2006) are derived from two critical care products, CroFab™ (pit viper antivenom) and DigiFab™ (digoxin antidote ...

Protherics PLC announces GBP 38 million Fundraising  -  Dec 8, 2006
Genetic Engineering News (press release),...of intellectual property from Glenveigh Pharmaceuticals LLC ("Glenveigh") for the use of ovine polyclonal antibody fragments (including DigiFab(R) and ...

Protherics Buys Digidot Rights To Corner Dioxin Overdose Area  -  Nov 27, 2006
Therapeutics Daily (subscription) (press release),...treatment Digitalis Antidot, or Digidot, from F. Hoffmann-La Roche Ltd., as a route to building an exclusive European franchise around DigiFab, its own ...

MacroMed Announces Acquisition by Protherics PLC  -  Dec 11, 2006
PR Newswire (press release),Europe. Protherics currently has two commercial products, CroFab(R), a pit viper antivenom, and DigiFab(R), a digoxin antidote. ...

GSK Acquiring Young Antibody Firm Domantis For $454M Cash  -  Dec 8, 2006
BioWorld Online,Pharmaceuticals LLC, of Research Triangle Park, NC, relating to the use of ovine polyclonal antibody fragments (including DigiFab and GlaxoSmithKline's Digibind ...

Protherics Announces £38 Million Fundraising, Two Strategic in ...  -  Dec 7, 2006
PharmaLive.com (press release),17.7 million in the year ended 31 March 2006) are derived from two critical care products, CroFab™ (pit viper antivenom) and DigiFab™ (digoxin antidote ...

MacroMed Announces Acquisition by Protherics PLC  -  Dec 11, 2006
Yahoo! News (press release)Europe. Protherics currently has two commercial products, CroFab®, a pit viper antivenom, and DigiFab®, a digoxin antidote. The ...

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional